QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.25%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-4.14%)
GE   106.06 (-0.02%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
NASDAQ:YTEN

Yield10 Bioscience (YTEN) Stock Forecast, Price & News

$2.48
-0.21 (-7.82%)
(As of 06/8/2023 ET)
Compare
Today's Range
$2.42
$2.76
50-Day Range
$2.48
$3.19
52-Week Range
$1.63
$4.19
Volume
26,722 shs
Average Volume
165,769 shs
Market Capitalization
$14.90 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Yield10 Bioscience MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
1.95% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
$999,999 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($1.84) to ($0.78) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.41 out of 5 stars

Consumer Staples Sector

126th out of 139 stocks

Agricultural Production - Crops Industry

11th out of 11 stocks


YTEN stock logo

About Yield10 Bioscience (NASDAQ:YTEN) Stock

Yield10 Bioscience, Inc. is an agricultural bioscience company, which engages in the development of oilseed Camelina sativa as a platform crop for large scale production of low carbon sustainable seed products. The company was founded by Anthony J. Sinskey, Simon F. Williams, and Oliver P. Peoples in 1992 and is headquartered in Woburn, MA.

Receive YTEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Yield10 Bioscience and its competitors with MarketBeat's FREE daily newsletter.

YTEN Stock News Headlines

Yield10 Bioscience, Inc. (NASDAQ:YTEN) Short Interest Update
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
Sell Every Stock, Except ONE (Ticker Revealed)
We saw one of the longest bull markets in history, with the S&P surging well over 800% But now the chickens have come home to roost. However, Jeff Clark couldn’t care less because he ignores almost every single stock in the market.
Maxim Group Remains a Buy on Yield10 Bioscience (YTEN)
Lake Street Sticks to Its Buy Rating for Yield10 Bioscience (YTEN)
8-K: YIELD10 BIOSCIENCE, INC.
See More Headlines

YTEN Price History

YTEN Company Calendar

Last Earnings
3/14/2023
Today
6/08/2023
Next Earnings (Estimated)
8/09/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Agricultural production - crops
Sub-Industry
N/A
Current Symbol
NASDAQ:YTEN
Employees
29
Year Founded
1992

Profitability

Net Income
$-13,570,000.00
Net Margins
-3,882.82%
Pretax Margin
-3,842.10%

Debt

Sales & Book Value

Annual Sales
$450,000.00
Book Value
$0.89 per share

Miscellaneous

Free Float
5,701,000
Market Cap
$15.65 million
Optionable
Not Optionable
Beta
1.81

Social Links


Key Executives

  • Oliver P. Peoples
    President, Chief Executive Officer & Director
  • Charles B. HaaserCharles B. Haaser
    Chief Accounting Officer, Treasurer & VP-Finance
  • Kristi D. Snell
    Chief Science Officer & Vice President-Research
  • Nicholas Renegar
    Director-Business Analytics & Operations
  • Lynne H. Brum
    Secretary, VP-Planning & Communications













YTEN Stock - Frequently Asked Questions

How have YTEN shares performed in 2023?

Yield10 Bioscience's stock was trading at $1.6695 at the start of the year. Since then, YTEN stock has increased by 55.7% and is now trading at $2.60.
View the best growth stocks for 2023 here
.

Are investors shorting Yield10 Bioscience?

Yield10 Bioscience saw a drop in short interest during the month of May. As of May 15th, there was short interest totaling 78,000 shares, a drop of 27.8% from the April 30th total of 108,000 shares. Based on an average daily volume of 43,600 shares, the short-interest ratio is presently 1.8 days. Approximately 2.0% of the shares of the company are sold short.
View Yield10 Bioscience's Short Interest
.

When is Yield10 Bioscience's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 9th 2023.
View our YTEN earnings forecast
.

How were Yield10 Bioscience's earnings last quarter?

Yield10 Bioscience, Inc. (NASDAQ:YTEN) released its quarterly earnings results on Tuesday, March, 14th. The specialty chemicals company reported ($0.67) earnings per share for the quarter. The specialty chemicals company had revenue of $0.09 million for the quarter. Yield10 Bioscience had a negative net margin of 3,882.82% and a negative trailing twelve-month return on equity of 243.41%.

When did Yield10 Bioscience's stock split?

Yield10 Bioscience shares reverse split on the morning of Thursday, January 16th 2020. The 1-40 reverse split was announced on Wednesday, January 15th 2020. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, January 15th 2020. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

What other stocks do shareholders of Yield10 Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Yield10 Bioscience investors own include KushCo (KSHB), OPKO Health (OPK), T2 Biosystems (TTOO), FuelCell Energy (FCEL), TherapeuticsMD (TXMD), Viking Therapeutics (VKTX), Rigel Pharmaceuticals (RIGL), Advanced Micro Devices (AMD).

What is Yield10 Bioscience's stock symbol?

Yield10 Bioscience trades on the NASDAQ under the ticker symbol "YTEN."

Who are Yield10 Bioscience's major shareholders?

Yield10 Bioscience's stock is owned by a number of retail and institutional investors. Top institutional investors include Grand Wealth Management LLC (0.56%). Insiders that own company stock include Anthony J Sinskey, Charles B Haaser and Jack W Schuler.
View institutional ownership trends
.

How do I buy shares of Yield10 Bioscience?

Shares of YTEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Yield10 Bioscience's stock price today?

One share of YTEN stock can currently be purchased for approximately $2.60.

How much money does Yield10 Bioscience make?

Yield10 Bioscience (NASDAQ:YTEN) has a market capitalization of $15.65 million and generates $450,000.00 in revenue each year. The specialty chemicals company earns $-13,570,000.00 in net income (profit) each year or ($2.84) on an earnings per share basis.

How can I contact Yield10 Bioscience?

Yield10 Bioscience's mailing address is 19 PRESIDENTIAL WAY, WOBURN MA, 01801. The official website for the company is www.yield10bio.com. The specialty chemicals company can be reached via phone at (617) 583-1700, via email at brets@coreir.com, or via fax at 617-583-1768.

This page (NASDAQ:YTEN) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -